Comparison of Single Agent Gemcitabine and Docetaxel in Second-Line Therapy for Advanced Stage Non-Small Cell Lung Cancer in a University Hospital in Turkey

Title
Comparison of Single Agent Gemcitabine and Docetaxel in Second-Line Therapy for Advanced Stage Non-Small Cell Lung Cancer in a University Hospital in Turkey
Authors
Keywords
-
Journal
Asian Pacific Journal of Cancer Prevention
Volume 16, Issue 17, Pages 7859-7863
Publisher
Asian Pacific Organization for Cancer Prevention
Online
2016-01-18
DOI
10.7314/apjcp.2015.16.17.7859

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started